Paracetamol Not Banned in India, Says Union Minister Amid Rumours

In a firm clarification during the Monsoon Session of Parliament, Union Minister of State for Chemicals and Fertilisers Anupriya Patel confirmed that the government has not banned the commonly used pain-relief drug paracetamol in India. This statement comes amidst confusion and public concern over the drug’s regulatory status.

 No Ban on Paracetamol, Clarifies CDSCO

 

Patel stated that thehttp://Central Drugs Standard Control Organisation Central Drugs Standard Control Organisation (CDSCO) has not received any notification or initiated any ban on paracetamol in India. She emphasized that there is no regulatory decision to halt its use, debunking social media claims about its prohibition.

 

 Ban on Some Drug Combinations Only

However, the minister did clarify that while paracetamol alone is not banned, certain Fixed Dose Combinations (FDCs) that include paracetamol with other ingredients have been banned for safety reasons. These bans are based on rigorous clinical assessments and aim to prevent irrational combinations that may harm public health.

Free Essential Drug Services Under NHM

In a proactive move to reduce out-of-pocket medical expenses for Indian families, the government has launched a Free Drugs Service Initiative under the National Health Mission (NHM). This ensures free access to essential medicines in government hospitals and rural health facilities across states.

 

Financial Support for State Procurement

 

Patel shared that financial assistance is being given to states to procure drugs, improve warehousing, implement quality assurance, and maintain transparent supply chains. The Ministry also promotes use of the Drugs and Vaccine Distribution Management System (DVDMS) — a tech platform that tracks availability and distribution of essential medicines in real-time.

 

Facility-wise Drug List to Improve Access

 

To streamline drug availability, the Ministry of Health has recommended facility-specific Essential Medicines Lists (EMLs). For example:

 

106 drugs for Sub-Health Centres

172 for Primary Health Centres

300+ for District Hospitals

States are allowed to add more drugs as per local needs,  yet accountable framework.

Related Posts

Almost 85% of overcharged amount claimed by NPPA yet to be recovered

New Delhi: India’s drug price monitoring and enforcing authority, the National Pharmaceutical Pricing Authority (NPPA), has almost 85 per cent of the amount it demanded from the pharma industry on…

Jharkhand’s Blood Scandal: Govt Suspends Officials, Launches Probes Amid Calls for NAT Testing Mandate

Ranchi–  In a heartbreaking breach of medical trust, five thalassemia-afflicted children in Jharkhand’s West Singhbhum district have tested HIV-positive after receiving contaminated blood transfusions at Chaibasa Sadar Hospital, exposing glaring…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Sun Pharma Launches UNLOXCYT for Advanced Skin Cancer in US

Sun Pharma Launches UNLOXCYT for Advanced Skin Cancer in US

Unlicensed medical device stock worth Rs. 4.47 lakh seized in Gurugram raid

Unlicensed medical device stock worth Rs. 4.47 lakh seized in Gurugram raid

Controlled substances charge: Court summons Ramdev, Amazon founder

Controlled substances charge: Court summons Ramdev, Amazon founder

Allahabad HC refuses to quash case against pharma company linked to cough syrup deaths in Uzbekistan

Allahabad HC refuses to quash case against pharma company linked to cough syrup deaths in Uzbekistan

IPC registers 44 small-scale medtech firms under ADRMS

IPC registers 44 small-scale medtech firms under ADRMS

Over 9,000 deaths due to respiratory diseases in Delhi

Over 9,000 deaths due to respiratory diseases in Delhi